Value Partners Investments Inc. Acquires 10,000 Shares of Medtronic PLC $MDT

Value Partners Investments Inc. raised its holdings in Medtronic PLC (NYSE:MDT) by 10.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 105,546 shares of the medical technology company’s stock after acquiring an additional 10,000 shares during the quarter. Medtronic accounts for approximately 0.8% of Value Partners Investments Inc.’s investment portfolio, making the stock its 25th largest holding. Value Partners Investments Inc.’s holdings in Medtronic were worth $10,140,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Artisan Partners Limited Partnership grew its position in Medtronic by 2.6% in the third quarter. Artisan Partners Limited Partnership now owns 1,234,550 shares of the medical technology company’s stock worth $117,579,000 after acquiring an additional 31,314 shares in the last quarter. AXQ Capital LP raised its position in Medtronic by 25.6% during the second quarter. AXQ Capital LP now owns 9,890 shares of the medical technology company’s stock valued at $862,000 after purchasing an additional 2,013 shares in the last quarter. CSM Advisors LLC raised its position in Medtronic by 13.2% during the third quarter. CSM Advisors LLC now owns 285,260 shares of the medical technology company’s stock valued at $27,169,000 after purchasing an additional 33,167 shares in the last quarter. UMB Bank n.a. lifted its stake in Medtronic by 65.8% during the third quarter. UMB Bank n.a. now owns 138,278 shares of the medical technology company’s stock worth $13,170,000 after purchasing an additional 54,898 shares during the last quarter. Finally, Applied Finance Capital Management LLC bought a new stake in Medtronic during the third quarter worth about $1,308,000. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on MDT shares. JPMorgan Chase & Co. reduced their price objective on Medtronic from $105.00 to $100.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 18th. Piper Sandler restated a “neutral” rating on shares of Medtronic in a research report on Monday, January 5th. Barclays reaffirmed an “overweight” rating and issued a $118.00 target price on shares of Medtronic in a research note on Wednesday, February 18th. Mizuho upgraded shares of Medtronic to a “strong-buy” rating in a research report on Wednesday, February 18th. Finally, Sanford C. Bernstein lifted their price target on shares of Medtronic from $111.00 to $112.00 and gave the stock an “outperform” rating in a research note on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $110.74.

Medtronic Stock Down 0.7%

MDT opened at $86.29 on Friday. The company has a market cap of $110.78 billion, a P/E ratio of 24.03, a P/E/G ratio of 2.21 and a beta of 0.71. The business’s 50-day moving average price is $96.82 and its 200-day moving average price is $96.69. The company has a current ratio of 2.54, a quick ratio of 1.87 and a debt-to-equity ratio of 0.57. Medtronic PLC has a 12 month low of $79.55 and a 12 month high of $106.33.

Medtronic (NYSE:MDT) last released its earnings results on Tuesday, February 17th. The medical technology company reported $1.36 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.02. The company had revenue of $9.02 billion during the quarter, compared to analyst estimates of $8.89 billion. Medtronic had a return on equity of 14.82% and a net margin of 13.00%.Medtronic’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.38 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, equities analysts expect that Medtronic PLC will post 5.46 EPS for the current year.

Medtronic Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 17th. Shareholders of record on Friday, March 27th will be given a $0.71 dividend. The ex-dividend date is Friday, March 27th. This represents a $2.84 annualized dividend and a yield of 3.3%. Medtronic’s payout ratio is presently 79.11%.

Insider Buying and Selling at Medtronic

In other news, EVP Harry Skip Kiil sold 52,524 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $97.71, for a total transaction of $5,132,120.04. Following the completion of the sale, the executive vice president owned 32,768 shares of the company’s stock, valued at approximately $3,201,761.28. This represents a 61.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.26% of the company’s stock.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).